查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
水腫臨床試驗市場 - 成長、未來展望、競爭分析，2023-2031
市場調查報告書
商品編碼
1397467

水腫臨床試驗市場 - 成長、未來展望、競爭分析，2023-2031

Edema Clinical Trials Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格

水腫臨床試驗市場經歷了重大演變，由於研究方法的進步以及對不同進入者群體的日益關注，預計在 2023-2031 年預測期內將以 5.5% 的複合年增長率增長。 隨著我們從收入可觀的 2022 年轉向 2023 年至 2031 年的預測期，水腫臨床試驗市場預計將繼續擴大。 臨床試驗中繼續採用的創新策略預計將塑造水腫治療的格局，解決不同患者群體的複雜性，並為更有效和以患者為中心的干預措施鋪平道路。

治療方法的進展

水腫臨床試驗市場的最□□大驅動力是治療方法的持續發展。 正在進行的臨床試驗正在探索創新機制，以更有效地解決水腫問題，新型候選藥物和乾預措施的出現證明了這一點。 針對特定途徑（例如血管通透性和淋巴功能）的研究性治療在早期試驗中顯示出有希望的結果。 這些進步反映了為提高治療效果和減少副作用而做出的共同努力，為更有針對性和個人化的治療鋪平了道路。

更重視兒科研究

塑造水腫臨床試驗格局的一個重要驅動力是對兒科研究的日益重視。 認識到兒科族群面臨的獨特挑戰和獨特的生理反應，最近的臨床試驗專注於開發專門針對兒童的實證幹預措施。 這一轉變透過將兒科隊列納入多階段試驗來證明，以確保針對該族群的水腫治療的安全性和有效性。 透過解決兒科患者未滿足的醫療需求，這些試驗有助於更全面地了解不同年齡層的水腫管理。

數位科技的不斷融合

推動水腫臨床試驗市場的另一個關鍵因素是數位技術的日益整合。 從電子數據採集系統到監測水腫相關參數的可穿戴設備，臨床試驗正在利用數位技術創新來提高數據準確性、簡化患者監測並提高整體試驗效率。 即時數據收集和分析使研究人員能夠做出明智的決策，加快臨床試驗的步伐，並有助於及時開發有效的水腫治療方法。

病患招募與留任的挑戰

水腫臨床試驗市場的一個主要限制因素是病患招募和保留的持續挑戰。 儘管治療方法和數位技術取得了進步，但招募多樣化且具代表性的參與者仍然是一個複雜的挑戰。 這種限制的證據是難以招募足夠數量的合格參與者，從而導致試驗持續時間更長和成本增加。 此外，在一些試驗中觀察到的高流失率凸顯了需要創新策略來提高患者在整個試驗期間的參與度和保留率。

III 期試驗主導市場

2022年水腫臨床試驗市場在不同階段都有可觀的收入，其中III期試驗收入最高。 然而，IV 期試驗顯示在 2023-2031 年預測期內複合年增長率最高。 這代表著向上市後監測和對長期治療結果的持續探索的轉變。 這種動態細分突顯了水腫臨床研究的不斷發展的性質，重點是晚期和上市後監測。

依參與者劃分：成人細分市場主導市場

2022 年市場參與者細分顯示，成人收入強勁，反映出臨床試驗對此細分市場的關注。 然而，預測期內複合年增長率最高的是兒科，凸顯了人們越來越認識到兒科研究在解決年輕人水腫的重要性。 同時，老年病學展示了一種綜合方法，在臨床試驗設計中考慮了老年患者的獨特特徵，並保持了強勁的收入。

北美仍處於世界領先地位

2022年水腫臨床試驗市場呈現地理差異化趨勢，其中北美收入領先。 然而，亞太地區的複合年增長率最高，反映出臨床試驗活動的激增和研究基礎設施投資的增加。 考慮到收入和複合年增長率之間的平衡，這些地理趨勢凸顯了水腫臨床試驗的全球性質，不同地區對研究進展做出了獨特的貢獻。

預測期內市場競爭將會加劇

在競爭格局中，Pfizer, Novartis, Johnson & Johnson, Otsuka Holdings, F. Hoffmann-La Roche, Bayer, Genentech, Biogen, Inflammasome Therapeutics, Sanofi, OcuTerra Therapeutics等大公司都在進行技術創新。塑造水腫臨床試驗的未來。 這些主要公司預計將在 2022 年實現可觀收入，並在 2023 年至 2031 年期間繼續成長。 他們的策略重點是開發先進的治療方法、強調兒科研究和利用數位技術，這使他們成為水腫臨床試驗領域的一支有影響力的力量。 隨著市場的發展，這些參與者預計將在推進臨床研究方面發揮關鍵作用，並最終為開發更有效的水腫治療方法做出貢獻。

目錄

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 提供的主要產品
  • 市場區隔
  • 調查方法
    • 第一階段-二次調查
    • 第二階段 - 初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

第三章水腫臨床試驗市場：競爭分析

  • 主要供應商的市場地位
  • 供應商採取的策略
  • 主要產業戰略
  • 層級分析：2022 年與 2031 年

第四章水腫臨床試驗市場：宏觀分析與市場動態

  • 簡介
  • 2021-2031年全球水腫臨床試驗市場價值
  • 市場動態
    • 市場驅動因素
    • 市場限制因素
    • 主要挑戰
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析
  • Portela 的五力模型 € (TM)
    • 供應商實力
    • 買家力量
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的對抗關係
  • PESTEL 分析
    • 政治局勢
    • 經濟情勢
    • 技術版圖
    • 法律狀況
    • 社會狀況

第五章水腫臨床試驗市場：依階段 2021-2031

  • 市場概覽
  • 成長/利潤分析：2022 年與 2031 年
  • 市場區隔
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段

第 6 章水腫臨床試驗市場：依參與者 2021-2031

  • 市場概覽
  • 成長/利潤分析：2022 年與 2031 年
  • 市場區隔
    • 兒科
    • 成人
    • 老年醫學

第 7 章水腫臨床試驗市場：依研究設計 2021-2031

  • 市場概覽
  • 成長/利潤分析：2022 年與 2031 年
  • 市場區隔
    • 幹預試驗
    • 觀察測試
    • 擴充存取試用版

第 8 章水腫臨床試驗市場：依類型 2021-2031

  • 市場概覽
  • 成長/利潤分析：2022 年與 2031 年
  • 市場區隔
    • 全身水腫
    • 局部水腫

第九章北美水腫臨床試驗市場2021-2031

  • 市場概覽
  • 水腫臨床試驗市場：依階段 2021-2031
  • 水腫臨床試驗市場：依參與者劃分，2021-2031 年
  • 水腫臨床試驗市場：依研究設計 2021-2031
  • 水腫臨床試驗市場：依類型 2021-2031
  • 水腫臨床試驗市場：依地區劃分 2021-2031
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 10 章英國與歐盟水腫臨床試驗市場 2021-2031

  • 市場概覽
  • 水腫臨床試驗市場：依階段 2021-2031
  • 水腫臨床試驗市場：依參與者劃分，2021-2031 年
  • 水腫臨床試驗市場：依研究設計 2021-2031
  • 水腫臨床試驗市場：依類型 2021-2031
  • 水腫臨床試驗市場：依地區劃分 2021-2031
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 其他歐洲地區

第11章亞太水腫臨床試驗市場2021-2031

  • 市場概覽
  • 水腫臨床試驗市場：依階段 2021-2031
  • 水腫臨床試驗市場：依參與者劃分，2021-2031 年
  • 水腫臨床試驗市場：依研究設計 2021-2031
  • 水腫臨床試驗市場：依類型 2021-2031
  • 水腫臨床試驗市場：依地區劃分 2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第十二章拉丁美洲水腫臨床試驗市場2021-2031

  • 市場概覽
  • 水腫臨床試驗市場：依階段 2021-2031
  • 水腫臨床試驗市場：依參與者劃分，2021-2031 年
  • 水腫臨床試驗市場：依研究設計 2021-2031
  • 水腫臨床試驗市場：依類型 2021-2031
  • 水腫臨床試驗市場：依地區劃分 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第十三章2021-2031年中東及非洲水腫臨床試驗市場

  • 市場概覽
  • 水腫臨床試驗市場：依階段 2021-2031
  • 水腫臨床試驗市場：依參與者劃分，2021-2031 年
  • 水腫臨床試驗市場：依研究設計 2021-2031
  • 水腫臨床試驗市場：依類型 2021-2031
  • 水腫臨床試驗市場：依地區劃分 2021-2031
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲地區

第十四章公司簡介

  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson
  • Otsuka Holdings
  • F. Hoffmann-La Roche Ltd.
  • Bayer
  • Genentech Inc
  • Biogen
  • Inflammasome Therapeutics
  • Sanofi S.A.
  • OcuTerra Therapeutics
  • 其他主要公司
Product Code: 140025-12-23

The edema clinical trials market is undergoing significant advancements and is expected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2031, fueled by evolving research methodologies and a growing focus on diverse participant demographics. As we transition from 2022, marked by substantial revenues, to the forecast period of 2023 to 2031, the Edema Clinical Trials market is poised for continued expansion. The ongoing innovative strategies employed in clinical trials are expected to shape the landscape of edema treatment, addressing the complexities of diverse patient populations and paving the way for more effective and patient-centric interventions.

Advancements in Therapeutic Approaches

The foremost driver in the Edema Clinical Trials market is the continuous evolution of therapeutic approaches. As evidenced by the emergence of novel drug candidates and interventions, ongoing clinical trials are exploring innovative mechanisms to address edema more effectively. Investigational treatments targeting specific pathways, such as vascular permeability and lymphatic function, have demonstrated promising results in early-phase trials. These advancements reflect a concerted effort to enhance treatment efficacy and reduce adverse effects, paving the way for more targeted and personalized interventions.

Increased Emphasis on Pediatric Research

A crucial driver shaping the landscape of edema clinical trials is the increased emphasis on pediatric research. Recognizing the unique challenges and distinct physiological responses in pediatric populations, recent trials have focused on developing evidence-based interventions specifically tailored to children. This shift is evident in the inclusion of pediatric cohorts in multi-phase trials, ensuring the safety and efficacy of edema treatments for this demographic. By addressing the unmet medical needs of pediatric patients, these trials contribute to a more comprehensive understanding of edema management across diverse age groups.

Growing Integration of Digital Technologies

Another key driver propelling the Edema Clinical Trials market is the growing integration of digital technologies. From electronic data capture systems to wearable devices monitoring edema-related parameters, clinical trials are leveraging digital innovations to enhance data accuracy, streamline patient monitoring, and improve overall trial efficiency. Real-time data collection and analysis enable researchers to make informed decisions, accelerating the pace of clinical trials and contributing to the timely development of effective edema treatments.

Challenges in Patient Recruitment and Retention

A significant restraint in the Edema Clinical Trials market is the persistent challenge of patient recruitment and retention. Despite the advancements in therapeutic approaches and digital technologies, enrolling a diverse and representative participant pool remains a complex task. Evidence supporting this restraint includes instances of prolonged trial timelines and increased costs due to difficulties in recruiting a sufficient number of eligible participants. Additionally, the high attrition rates observed in some trials underscore the need for innovative strategies to enhance patient engagement and retention throughout the trial duration.

By Phase: Phase III trials Dominates the Market

In 2022, the Edema Clinical Trials market experienced substantial revenue across different phases, with Phase III trials generating the highest revenue. However, Phase IV trials demonstrated the highest CAGR during the forecast period from 2023 to 2031, indicating a shift towards post-marketing research and continued exploration of long-term treatment outcomes. This dynamic segmentation underscores the evolving nature of clinical research in edema, emphasizing both advanced stages and post-marketing surveillance.

By Participant: The Adults Segment Dominates the Market

Market segmentation by participants in 2022 showcased robust revenue streams from adults, reflecting the predominant focus on this demographic in clinical trials. However, Pediatrics demonstrated the highest CAGR during the forecast period, highlighting a growing recognition of the importance of pediatric research in addressing edema in younger populations. Simultaneously, Geriatrics maintained substantial revenue, illustrating a comprehensive approach that considers the unique characteristics of elderly patients in clinical trial design.

North America Remains the Global Leader

Geographically, the Edema Clinical Trials market exhibited diverse trends in 2022, with North America leading in revenue generation. However, the Asia-Pacific region showcased the highest CAGR, reflecting a surge in clinical trial activities and increasing investment in research infrastructure. Balancing revenue and CAGR, these geographic trends underscore the global nature of edema clinical trials, with diverse regions contributing uniquely to research advancements.

Market Competition to Intensify during the Forecast Period

In the competitive landscape, top players such as Pfizer Inc., Novartis AG, Johnson & Johnson, Otsuka Holdings, F. Hoffmann-La Roche Ltd., Bayer, Genentech, Inc, Biogen, Inflammasome Therapeutics, Sanofi S.A. and OcuTerra Therapeutics are driving innovation and shaping the future of edema clinical trials. These key players reported substantial revenues in 2022, expecting continued growth from 2023 to 2031. Their strategic focus on developing advanced therapeutic approaches, emphasizing pediatric research, and leveraging digital technologies positions them as influential entities in the edema clinical trials landscape. As the market evolves, these players are anticipated to play a pivotal role in advancing clinical research, ultimately contributing to the development of more effective treatments for edema.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEdema Clinical Trials market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Edema Clinical Trials market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Phase

    • Phase I
    • Phase II
    • Phase III
    • Phase IV

Participant

    • Pediatrics
    • Adults
    • Geriatrics

Study Design

    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials

Type

    • Systemic Edema
    • Localized Edema

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Edema Clinical Trials market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Edema Clinical Trials market?

Which is the largest regional market for Edema Clinical Trials market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Edema Clinical Trials market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Edema Clinical Trials market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Edema Clinical Trials Market
  • 2.2. Global Edema Clinical Trials Market, By Phase, 2022 (US$ Million)
  • 2.3. Global Edema Clinical Trials Market, By Participant, 2022 (US$ Million)
  • 2.4. Global Edema Clinical Trials Market, By Study Design, 2022 (US$ Million)
  • 2.5. Global Edema Clinical Trials Market, By Type, 2022 (US$ Million)
  • 2.6. Global Edema Clinical Trials Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Edema Clinical Trials Market: Competitive Analysis

  • 3.1. Market Positioning of Key Edema Clinical Trials Market Vendors
  • 3.2. Strategies Adopted by Edema Clinical Trials Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Edema Clinical Trials Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Edema Clinical Trials Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Phase I
    • 5.3.2. Phase II
    • 5.3.3. Phase III
    • 5.3.4. Phase IV

6. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Pediatrics
    • 6.3.2. Adults
    • 6.3.3. Geriatrics

7. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Interventional Trials
    • 7.3.2. Observational Trials
    • 7.3.3. Expanded Access Trials

8. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Systemic Edema
    • 8.3.2. Localized Edema

9. North America Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 9.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 9.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 9.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 9.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 9.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 9.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 9.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 9.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 9.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 9.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 9.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 9.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 9.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

10. UK and European Union Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 10.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 10.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 10.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 10.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

11. Asia Pacific Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 11.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 11.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 11.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 11.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

12. Latin America Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 12.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 12.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 12.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 12.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 12.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 12.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 12.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 12.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 12.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 12.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 12.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 12.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 12.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

13. Middle East and Africa Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 13.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 13.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 13.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 13.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 13.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 13.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 13.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 13.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 13.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 13.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 13.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 13.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 13.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Pfizer Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Novartis AG
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Johnson & Johnson
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Otsuka Holdings
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. F. Hoffmann-La Roche Ltd.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Bayer
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Genentech, Inc
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Biogen
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Inflammasome Therapeutics
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Sanofi S.A.
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. OcuTerra Therapeutics
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Other Notable Players
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 2 Global Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 3 Global Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 4 Global Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 5 North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 6 North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 7 North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 8 North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 9 U.S. Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 10 U.S. Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 11 U.S. Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 12 U.S. Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 13 Canada Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 14 Canada Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 15 Canada Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 16 Canada Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 17 Rest of North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 19 Rest of North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 20 Rest of North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 21 UK and European Union Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 23 UK and European Union Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 24 UK and European Union Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 25 UK Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 26 UK Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 27 UK Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 28 UK Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 29 Germany Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 30 Germany Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 31 Germany Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 32 Germany Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 33 Spain Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 34 Spain Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 35 Spain Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 36 Spain Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 37 Italy Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 38 Italy Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 39 Italy Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 40 Italy Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 41 France Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 42 France Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 43 France Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 44 France Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 45 Rest of Europe Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 47 Rest of Europe Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 48 Rest of Europe Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 49 Asia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 50 Asia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 51 Asia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 52 Asia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 53 China Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 54 China Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 55 China Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 56 China Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 57 Japan Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 58 Japan Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 59 Japan Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 60 Japan Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 61 India Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 62 India Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 63 India Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 64 India Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 65 Australia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 66 Australia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 67 Australia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 68 Australia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 69 South Korea Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 70 South Korea Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 71 South Korea Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 72 South Korea Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 73 Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 74 Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 75 Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 76 Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 77 Brazil Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 78 Brazil Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 79 Brazil Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 80 Brazil Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 81 Mexico Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 82 Mexico Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 83 Mexico Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 84 Mexico Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 85 Rest of Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 87 Rest of Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 88 Rest of Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 89 Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 91 Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 92 Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 93 GCC Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 94 GCC Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 95 GCC Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 96 GCC Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 97 Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 98 Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 99 Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 100 Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Edema Clinical Trials Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Edema Clinical Trials Market: Quality Assurance
  • FIG. 5 Global Edema Clinical Trials Market, By Phase, 2022
  • FIG. 6 Global Edema Clinical Trials Market, By Participant, 2022
  • FIG. 7 Global Edema Clinical Trials Market, By Study Design, 2022
  • FIG. 8 Global Edema Clinical Trials Market, By Type, 2022
  • FIG. 9 Global Edema Clinical Trials Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global Edema Clinical Trials Market, 2022

FIG. 11Market Positioning of Key Edema Clinical Trials Market Players, 2022

FIG. 12Global Edema Clinical Trials Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 13 Global Edema Clinical Trials Market, By Phase, 2022 Vs 2031, %
  • FIG. 14 Global Edema Clinical Trials Market, By Participant, 2022 Vs 2031, %
  • FIG. 15 Global Edema Clinical Trials Market, By Study Design, 2022 Vs 2031, %
  • FIG. 16 Global Edema Clinical Trials Market, By Type, 2022 Vs 2031, %
  • FIG. 17 U.S. Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 20 UK Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 24 France Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 26 China Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 28 India Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa Edema Clinical Trials Market (US$ Million), 2021 - 2031